COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study

VIP study investigators, James L. Alexander, Nicholas A. Kennedy, Hajir Ibraheim, Sulak Anandabaskaran, Aamir Saifuddin, Rocio Castro Seoane, Zhigang Liu, Rachel Nice, Claire Bewshea, Andrea D'Mello, Laura Constable, Gareth R. Jones, Sharmili Balarajah, Francesca Fiorentino, Shaji Sebastian, Peter M. Irving, Lucy C. Hicks, Horace R.T. Williams, Alexandra J. KentRachel Linger, Miles Parkes, Klaartje Kok, Kamal V. Patel, Julian P. Teare, Daniel M. Altmann, Rosemary J. Boyton, James R. Goodhand, Ailsa L. Hart, Charlie W. Lees, Tariq Ahmad, Nick Powell*, Ijeoma Chukwurah, Sulaimaan Haq, Parita Shah, Stephanie Wilken-Smith, Anitha Ramanathan, Mikin Patel, Lidia Romanczuk, Rebecca King, Jason Domingo, Djamila Shamtally, Vivien Mendoza, Joanne Sanchez, Hannah Stark, Bridget Knight, Louise Bee, Charmaine Estember, Anna Barnes, Darcy Watkins, Sam Stone

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

110 Citations (Scopus)

Fingerprint

Dive into the research topics of 'COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study'. Together they form a unique fingerprint.

Immunology and Microbiology